Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Phase II Study With Bendamustin for Patients With Refractory Soft Tissue Sarcoma

NCT00204620 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.

NCT NCT00204620
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00204620 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Phase II Study With Bendamustin for Patients With Refractory Soft Tissue Sarcoma
Lead sponsor
University Hospital Tuebingen
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2002
Completion date
December 31, 2006
Enrollment
28
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sarcoma, soft tissue